Kidney Transplant as a Treatment Option

Technical excellence and a genuine interest and concern for people are three of the most distinguishing characteristics that describe the staff at the Barnabas Health Renal and Pancreas Transplant Division. Add clinical research and patient advocacy to the picture and you can begin to see why people prefer the premier program that has served New Jersey and out-of-state residents for more than 30 years in the field of renal transplantation. This nationally respected team of nephrologists and surgeons, working closely with experienced registered nurses, social workers and support staff, offers an increasing number of transplant opportunities for people who choose this treatment alternative, and hope to many whose medical conditions previously prevented transplantation as an option.

Transplant recipients are experiencing an improved quality of life, independent of dialysis and its restrictions, through living or deceased donor donation, simultaneous pancreas-kidney, pancreas-after-kidney transplant and pediatric kidney transplantation programs that consistently achieve outstanding success rates.

Transplant candidates meet team members, talk with transplant recipients, and learn more about kidney transplantation at small informal educational sessions scheduled weekly at the Barnabas Health Renal and Pancreas Transplant Programs, located at Newark Beth Israel Medical Center and Saint Barnabas Medical Center in Livingston. Blending the most modern technology and resources with attentive personalized care available at two of New Jersey's leading medical institutions, Barnabas Health Renal and Pancreas Transplant Programs provide comprehensive support for patients and their families throughout the process of obtaining a transplant and maintaining a healthy organ.

Both Newark Beth Israel Medical Center and Saint Barnabas Medical Center offer a Bloodless Surgery Program.

The world-class Renal and Pancreas Transplant Division of Barnabas Health is one of the world's most progressive transplant programs and one of the largest programs among 240 in the United States. In 2014, the Division performed 247 transplants, including 131 living donor transplants. The Department of Transplant Research is participating in clinical drug trials and investigating the most current anti-rejection medications available.

[ top ]